Second Lawsuit from Pfizer to Novo Nordisk!

Pfizer, Novo Nordisk, and biotechnology company Metsera have filed a second lawsuit against each other. This lawsuit has emerged to stop Novo Nordisk's acquisition attempt in the biotechnology field.

The lawsuit continues as Pfizer claims that Novo Nordisk's desire to acquire the biotechnology company constitutes unfair competition. This advanced legal process is also drawing attention for its impact on the industry.